Hrt Financial LP Century Therapeutics, Inc. Transaction History
Hrt Financial LP
- $20.6 Billion
- Q3 2025
A detailed history of Hrt Financial LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 18,113 shares of IPSC stock, worth $8,513. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,113
Previous 111,064
83.69%
Holding current value
$8,513
Previous $62,000
85.48%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPSC
# of Institutions
56Shares Held
22.5MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA3.54MShares$1.66 Million0.57% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.59MShares$1.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.1MShares$988,8180.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$800,9890.23% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $27.7M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...